Back to Search
Start Over
An Overview on COVID-19 and its Effect on Cardiovascular Diseases
- Source :
- Endocrine, Metabolic & Immune Disorders - Drug Targets. 21:1949-1953
- Publication Year :
- 2021
- Publisher :
- Bentham Science Publishers Ltd., 2021.
-
Abstract
- Abstract:: COVID-19 (Virus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) is a pandemic disease characterized with respiratory infection caused by coronavirus. It has worldwide after an outbreak began in Wuhan, China, in December 2019. SARS-CoV-2 has infected more than 15 million people globally. The disease severity and mortality increased in patients with heart-related comorbidities. Cardiovascular disease patients are more susceptible and infected with SARS-CoV-2. Early screening and managements these patients prevent or ameliorate adverse outcomes. Several treatments have been used to combat these effects as previously seen in MERS and SARS. This review will cover the association of cardiovascular diseases with COVID 19. It showed that cardiovascular diseases are common in patients with COVID- 19. Increased attention to highlight the gaps should be paid to the care of this unique group of patients.
- Subjects :
- medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Heart disease
Endocrinology, Diabetes and Metabolism
Comorbidity
Disease
medicine.disease_cause
Risk Assessment
Virus
Risk Factors
Internal medicine
Pandemic
medicine
Humans
Immunology and Allergy
Coronavirus
SARS-CoV-2
business.industry
COVID-19
Respiratory infection
Outbreak
Prognosis
medicine.disease
Cardiovascular Diseases
Host-Pathogen Interactions
Heart Transplantation
business
Subjects
Details
- ISSN :
- 18715303
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Endocrine, Metabolic & Immune Disorders - Drug Targets
- Accession number :
- edsair.doi.dedup.....55c7e87732f072a51e604da481892180